As dozens of companies and universities rush to develop a coronavirus vaccine, the US will also have to grapple with who will get a vaccine first once it's been approved by the Food and Drug Administration.
A team at the University of Oxford says they can have a million doses of a COVID-19 vaccine ready by September.
"Most importantly that means bringing down the infection rate - and that can only be achieved if we continue to obey the rules on social distancing to help stop it spreading".
"I'm very proud of how quickly our scientists and researchers have come together in their efforts developing a vaccine that will combat coronavirus".
"We can also ensure that in addition to supporting people here in the United Kingdom, we're able to make the vaccine available to developing countries at the lowest possible cost".
Encounter Breaks Out Between Security Forces and Terrorists In Srinagar
There have been a number of gunfights between militants and security forces in Jammu and Kashmir over the past month. A CRPP man and a Jammu and Kashmir police personnel were injured in the firing by militants, police said.
Sharma confirmed that Oxford University has signed a global licensing agreement with pharmaceutical giant AstraZeneca for commercialization and manufacturing of the vaccine. The rapid deployment facility will ensure that the vaccine is widely available to all the United Kingdom public within a short time, cited Sharma.
Business Secretary Alok Sharma said: "As the biggest contributor to the worldwide coalition to find a vaccine, the United Kingdom is leading the global response".
Ms Halton, chair of the Coalition for Epidemic Preparedness Innovations, believes there's a reasonable chance a vaccine will be found for COVID-19. "The speed at which Oxford University has designed and organised these complex trials is genuinely unprecedented", he added.
The government has also announced funding towards a temporary facility to allow the United Kingdom to manufacture doses this summer, if a vaccine is found.
Moderna kicked off the early data around the vaccine race and released the first data from its phase 1 trial of SARS-CoV-2 vaccine mRNA-1273 on May 18, in conjunction with data supporting efficacy of the vaccine in mice.
World Health Organization pledges 'independent evaluation' of the global coronavirus response
Earlier, Mr Trump called World Health Organization "puppet of China " and had "done a very sad job" in its handling of the coronavirus.
Fauci said during his testimony to Congress on Tuesday that there could be repercussions to rushing vaccine trials, McClatchy News reported.
"We're looking to get it by the end of the year if we can, maybe before", Trump said on Friday, according to NPR. "And we will be working with the government on what some of those ideas might be".
But the former Australian Department of Health head warns the public must be prepared in case a vaccine is not developed.
The British government is investing a further £84 million in the hunt for a coronavirus vaccine as ministers announced a ground-breaking deal which could make millions of doses available in the United Kingdom as early as September.
WHO's annual meeting begins amid tussle over coronavirus
He also vowed to work with other Group of 20 countries to carry out a debt relief initiative for "the poorest countries". However, Xi said that people across the globe "looked out for each other and pulled together as one".